Tetratricopeptide repeat domain 7A (TTC7A) deficiency is a very rare and severe hereditary disorder [1, 2] . Only a few cases have been reported to date. TTC7A, which is expressed in various cells, plays an important role in cellular processes such as cell polarity, gut and lymphocyte homeostasis, and development of T and B lymphocytes [3] . Mutations in this gene usually result in gastrointestinal defects and immunodeficiency. Variations in clinical manifestations have been observed in patients with TTC7A mutations. The most widely reported are combined immunodeficiency (CID) and gastrointestinal defects such as multiple intestinal atresia (MIA), diarrhea, and extensive enteropathy [2] . We report the case of a patient with gastrointestinal problems and immunodeficiency syndrome.
A 4-year-old girl born to consanguineous Iranian parents presented with recurrent pneumonia and chronic diarrhea. Her birth weight was 3 kg. She was the first of 2 children, her junior being a healthy 2.5-year-old brother. During the second year of life, she was hospitalized several times owing to recurrent pneumonia. She also experienced nonbloody and nongreasy diarrhea, which gradually worsened. At 39 months of age, she was admitted to hospital with pneumonia and severe diarrhea (10-12 times a day) that had led to a 4-kg weight loss. She was discharged after a 2-week stay in hospital with a prescription for elemental formula, since the diarrhea had not completely ceased.
In February 2017, her eyes and skin turned yellow. Therefore, she was hospitalized in the gastrointestinal department because of liver and gallbladder involvement, as well as persistent diarrhea. Liver biopsy showed cholestatic liver disease with significantly reduced bile ducts in portal areas. Consequently, she was diagnosed with vanishing bile duct syndrome and became a candidate for liver transplantation.
In July 2017, she was hospitalized because of lethargy and anorexia. Intravenous immunoglobulin (IVIG) was administered monthly because of hypogammaglobulinemia (IgG, 146 mg/dL; IgM, 12 mg/dL; IgA, 3 mg/dL). She was hospitalized owing to diarrhea and anorexia once again in September 2017.
Endoscopy and biopsy of the duodenum and stomach revealed erythema in the distal third of the esophagus, a large bleeding ulcer in the cardia, erosive gastritis, and moderate chronic gastritis with focal activity. Pathological findings in the biopsy specimens from the duodenum and antrum suggested autoimmune enteropathy and chronic erosive gastritis, respectively. Histopathology also revealed Helicobacter pylori.
Furthermore, high-resolution computed tomography of the lung revealed hyperaeration, mosaic attenuation, diffuse bronchiectasis, and peribronchial thickening. Additionally, atelectasis and consolidation were observed in the right middle lobe segment. Pleural effusion was not detected. A chest CT scan indicated right parahilar and left upper lobe alveolar consolidation, along with bronchiectasis in the right middle lobe. The main pulmonary artery was dilated, and pulmonary hypertension was suspected.
Magnetic resonance imaging revealed normal findings for the liver, spleen, pancreas, gallbladder, and kidney, although fluid dilation caused by ileus was observed in the small bowel and colon.
The lymphocyte and immunoglobulin profiles (normal range adapted from reference [4] ) were as follows: T-cell subsets, CD3, 1780 (1400-3700) cells/μL; CD4, 593 (700-2200) cells/μL; CD8, 333.7 (490-1300) cells/μL; B-cell subsets, CD19, 185.5 (390-1400) cells/μL; IgM, 84 mg/dL; IgG, 933 mg/dL; IgA, 8 mg/dL. These findings indicated T-cell lymphopenia (CD4 and CD8 deficiency) and B-cell lymphopenia. Despite the low levels of immunoglobulins, the evaluation of the antibody response to diphtheria and tetanus was normal. A delayed-type hypersensitivity test with tetanus toxoid and a PPD test were performed to evaluate the function of cell-mediated immunity. The results of these tests indicated dysfunction of cellular immunity.
Whole exome sequencing revealed a novel homozygous mutation in the TTC7A gene (NM_001288951: exon17: c.1955delA). This took the form of a frameshift deletion mutation (p.Q652fs) that is likely pathogenic based on most predictors. Sanger sequencing confirmed that the patient was homozygous and her parents were heterozygous for this mutation.
The clinical manifestations, laboratory findings, and genetic study revealed gastrointestinal defects and immunodeficiency syndrome. Unfortunately, at the age of 4 years, the patient died of hepatic encephalopathy when she was admitted for liver transplantation.
We report the case of a patient with a novel TTC7A mutation. To the best of our knowledge, there have been no previous reports of a frameshift deletion mutation in exon 17. Lawless et al [1] reported mutations of exon 17 in 3 patients, 2 of whom had MIA-CID, while common variable immunodeficiency accompanying enteropathy was reported in the third. Therefore, a missense mutation was identified in 2 patients and skipping of exon 17 in the TTC7A gene in 1 patient [1] .
Phenotypic variation of TTC7A mutations complicates timely diagnosis, with the result that different therapeutic procedures are required [5] . As stated in the literature review, up to three-quarters of patients with TTC7A mutations developed a CID phenotype. This abnormality stems from thymus failure and, consequently, defective lymphocyte development [5] . Despite the CD4 and CD8 deficiency in the patient we report, the T-cell count (CD3 + ) was normal. This discrepancy could be attributed to the presence of a doublenegative T-cell population (CD3 + CD4 -CD8 -). It has been suggested that these double-negative T cells are involved in regulation of T-cell activation [6] .
Recurrent diarrhea and enteropathy were major gastrointestinal problems in the present case. However, unlike some patients with TTC7A deficiency, this case indicated no evidence of intestinal atresia. It has been suggested that the absence of TTC7A protein could augment Rho kinase activity, and thereby growth, cell polarity, differentiation of intestinal cells, and cell homeostasis [3] .
Even though most patients with TTC7A mutations die in the early months of their lives [7] , the initial symptoms of the present patient manifested in the second year of life. As reported by Fernandez et al [7] , in addition to gastrointestinal effects and immunodeficiency, patients with TTC7A mutation could also show dysfunctions of other organs such as the thymus, liver, and lungs. We identified pulmonary and liver involvement in the case we report.
Syndromic diarrhea (tricho-hepato-enteric syndrome) is another autosomal recessive disease that shares clinical manifestations-diarrhea and immunodeficiency-with MIA-CID. This rare syndrome is the result of a defect in the TTC37 and SKIVL2 genes. Patients with the syndrome manifest other symptoms such as facial dysmorphism and hair, skin, and liver abnormalities [8] .
In conclusion, patients with gastrointestinal manifestations and immunodeficiency should be evaluated for mutations in TTC7A, TTC37, and SKIVL2 [8, 9] . The severity of this abnormality, its variable phenotypes, and overlapping syndromes require advanced diagnostic measures such as whole exome sequencing to differentiate between alternatives and make a timely diagnosis.
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Soybean is a legume from the oilseed family that is widely consumed by humans and animals owing to its high content in proteins, carbohydrates, and fiber [1] .
A Spanish study carried out in children revealed a positive result in 45%-85% of skin prick tests and specific IgE >0.7 kU/L against soybean, although fewer than 5% presented symptoms after consumption [2] . Heat treatment, fermentation, and high-pressure processing may affect the allergenic potential of soy products [3] .
We report the case of a 38-year-old man who experienced skin itching, facial angioedema, progressive dyspnea, low blood pressure, and loss of consciousness requiring hospitalization at an intensive care unit for 24 hours. The symptoms appeared 5-10 minutes after eating a premade white chocolate drink with almonds during the summer. At the time, he was being treated with finasteride, ibuprofen 600 mg (for joint pain, last dose 3-4 hours before onset of symptoms), omeprazole, and hemorrhoid cream. He reported no previous effort and had eaten steak and pasta for lunch (both tolerated after the episode). Tryptase levels during the episode were 4.2 µg/dL.
Previous allergy studies reported negative skin prick test results. Specific IgE against respiratory and food allergens (ISAC Microarray, Thermo Fisher) was negative to the whole panel, and challenge tests with ibuprofen and omeprazole were also negative. The patient had been advised to avoid nuts before coming to our clinic and tolerated chocolate without symptoms.
Skin prick tests were repeated with Dermatophagoides pteronyssinus, Alternaria species, dog and cat dander, grass pollen, olive tree pollen, Taraxacum species, milk, egg, wheat, gluten, gliadin, cashew, lupin bean, white fish, blue fish, shrimp, peanut, walnut, sunflower seed, peach LTP, latex, Anisakis species, cocoa, and sesame). Once again, the results were negative.
As the results of tests with the beverage components had all been negative and chocolate was unlikely to be the cause of the anaphylactic reaction, a challenge test was scheduled with the same white chocolate he had consumed
